Frontiers in Pharmacology | Pharmacoepidemiology

Original Research

Accepted on 02 Apr 2025

Charting the COVID-19 Vaccination Journey in Saudi Arabia: Insights into Post-Vaccination Adverse Effects and Immunization Dynamics

in Pharmacoepidemiology

GEHAD Subaiea
Nawaf Alkhateeb
Faisal Sahman
Abdulrahman Alsudayri
Abdulkarim Mohammed Almudayni
Hamoud Alrashidi
Abdulrahman Majid Alshammari
Abdulwahab Alamri
Sultan Ahmed Almuntashiri
Arshad Hussain

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1561410

Original Research

Accepted on 28 Mar 2025

Association of long-term use of dipeptidyl peptidase-4 inhibitors with the risk of diabetic retinopathy in patients with diabetes mellitus: A real-world evidence study

in Pharmacoepidemiology

Yu-Ching Li
Yu-Hsiang Kuan
Yih Yang
Shuo-Yan Gau
Kun-Yu Su
Tung-Han Tsai
Kuang-Hua Huang
Chien-Ying Lee

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1518545

Correction

Accepted on 26 Mar 2025

Mining and analysis of dizziness adverse event signals in postoperative analgesia patients based on the FDA adverse event reporting system database

in Pharmacoepidemiology

Fengqi Zhou
Haiou He
Jing Gao
Zhen Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1586073

Original Research

Published on 26 Mar 2025

Drug-induced herpes zoster: a pharmacovigilance analysis of FDA adverse event reports from 2004 to 2024

in Pharmacoepidemiology

Jiali Xia
Jing Zhang
Hongyu Zhu
Li Ding

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1565480

303 views

Original Research

Published on 26 Mar 2025

Community pharmacists’ views towards implementing a patient self-administered screening tool designed to identify risk of medication-related problems

in Pharmacoepidemiology

Mohammed S. Salahudeen
Ahmed Samy Saadeldean
Gregory M. Peterson
Behailu Terefe Tesfaye
Colin M. Curtain

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1531500

339 views

Original Research

Accepted on 25 Mar 2025

A real-world pharmacovigilance study of efgartigimod alfa in the FDA Adverse Event Reporting System database

in Pharmacoepidemiology

Yunlin Yang
Jinfeng Liu
Wei Wei

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1510992

251 views

Original Research

Published on 20 Mar 2025

The interaction between a leflunomide-response methylation site (cg17330251) and variant (rs705379) on response to leflunomide in patients with rheumatoid arthritis

in Pharmacoepidemiology

Feng Zhao
Yulan Chen
Haina Liu
Lei Jin
Xin Feng
Bingbing Dai
Meng Chen
Qiao Wang
Yuxin Yao
Ruobing Liao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1499723

217 views

Original Research

Accepted on 18 Mar 2025

Application of Global Trigger Tool to determine the prevalence of adverse drug reactions in adult patients admitted to general and COVID-19 intensive care units

in Pharmacoepidemiology

Rafael Nogueira De Souza
Patricia Moriel

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1514942

Systematic Review

Published on 18 Mar 2025

Correlation between UGT1A1 polymorphism and efficacy and toxicity of irinotecan in Chinese cancer patients

in Pharmacoepidemiology

Shuai Geng
Yulong Shen
Chen Zhang
Nan Wang
Xinyue Gao
Xinyu Luo
Ning Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1563566

266 views

Original Research

Published on 12 Mar 2025

Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database

in Pharmacoepidemiology

Chang-Zhu He
Qin Qiu
Song-Jie Lu
Fu-Li Xue
Jun-Qiao Liu
Yu He

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1521358

950 views

Original Research

Published on 12 Mar 2025

Real-world safety profile of elexacaftor/tezacaftor/ivacaftor: a disproportionality analysis using the U.S. FDA adverse event reporting system

in Pharmacoepidemiology

Chengyu Zhu
Zhiwei Cui
Tingting Liu
Siyu Lou
Linmei Zhou
Junyou Chen
Ruizhen Zhao
Li Wang
Yingyong Ou
Fan Zou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1531514

589 views

Original Research

Accepted on 10 Mar 2025

Incidence and Determinants of Excessive Weight Gain in People Living with HIV Initiating Tenofovir, Lamivudine, and Dolutegravir-Based Therapy: A Multicenter Retrospective Study in Northwest Ethiopia

in Pharmacoepidemiology

Gashaw Sisay Chanie
Wagaye Atalay
Tirsit Ketsela Zeleke
Zemenu Wube
Yonas Arage
Mihret Melese
Rahel Belete Abebe

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1394458

Original Research

Published on 10 Mar 2025

Development of a core outcome set for pharmacological interventions in osteoporosis among patients with diabetes mellitus: an international consensus study protocol

in Pharmacoepidemiology

Chao Wei
Xiaobin Wang
Zubing Mei
Jing Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1510968

549 views

Review

Published on 10 Mar 2025

A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX

in Pharmacoepidemiology

Ralf J. Ludwig
Matthew Anson
Henner Zirpel
Diamant Thaci
Henning Olbrich
Katja Bieber
Khalaf Kridin
Astrid Dempfle
Philip Curman
Sizheng S. Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1516126

1,176 views

Original Research

Published on 10 Mar 2025

Signal detection and safety analysis of three tyrosine kinase inhibitors for HER-2 positive breast cancer: a retrospective study based on the FAERS database

in Pharmacoepidemiology

Xiting Tang
Chengliang Wang
Yanwei Li
Jing Tang
Guoping Zhang
Li Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1538881

662 views

Original Research

Published on 05 Mar 2025

Non-chemotherapy drugs inducing agranulocytosis: a disproportionality analysis based on the FAERS database

in Pharmacoepidemiology

Shanshan Wu
Lina Huang
Jiajia Chen
Xiaochun Xie
Shaokai Huang
Xiaojie Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1525307

672 views